Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder

CONTEXT: Nicotine administration transiently improves many neurobiological and cognitive functions in schizophrenia. It is not yet clear which nAChR subtype(s) is responsible for these seemingly pervasive nicotinic effects in schizophrenia. OBJECTIVE: α4β2 is a key nAChR subtype for nicotinic action...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hong, L. Elliot, Thaker, Gunvant K., McMahon, Robert P., Summerfelt, Ann, RachBeisel, Jill, Fuller, Rebecca L., Wonodi, Ikwunga, Buchanan, Robert W., Myers, Carol, Heishman, Stephen J., Yang, Jeff, Nye, Adrienne
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3618988/
https://ncbi.nlm.nih.gov/pubmed/21810630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archgenpsychiatry.2011.83
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares